Stocks and Investing Stocks and Investing
Fri, December 8, 2023

Michael Yee Downgraded (BEAM) to Hold and Decreased Target to $30 on, Dec 8th, 2023


Published on 2024-10-28 07:54:43 - WOPRAI, Michael Yee
  Print publication without navigation


Michael Yee of Jefferies, Downgraded "Beam Therapeutics Inc." (BEAM) to Hold and Decreased Target from $75 to $30 on, Dec 8th, 2023.

Michael has made no other calls on BEAM in the last 4 months.



There are 4 other peers that have a rating on BEAM. Out of the 4 peers that are also analyzing BEAM, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Richard Law of "Credit Suisse" Maintained at Hold with Increased Target to $47 on, Wednesday, August 9th, 2023


These are the ratings of the 2 analyists that currently disagree with Michael


  • Rick Bienkowski of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $32 on, Tuesday, October 17th, 2023
  • Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Decreased Target to $56 on, Wednesday, August 9th, 2023
Contributing Sources